nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCG2—Dactinomycin—sarcoma	0.112	0.155	CbGbCtD
Telmisartan—ABCG2—Mitoxantrone—sarcoma	0.1	0.139	CbGbCtD
Telmisartan—ABCC2—Vincristine—sarcoma	0.0761	0.106	CbGbCtD
Telmisartan—ABCC2—Etoposide—sarcoma	0.0697	0.0969	CbGbCtD
Telmisartan—ABCG2—Vincristine—sarcoma	0.0688	0.0957	CbGbCtD
Telmisartan—ABCG2—Etoposide—sarcoma	0.063	0.0877	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—sarcoma	0.0476	0.0661	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—sarcoma	0.043	0.0598	CbGbCtD
Telmisartan—ABCB1—Dactinomycin—sarcoma	0.0403	0.056	CbGbCtD
Telmisartan—ABCB1—Mitoxantrone—sarcoma	0.036	0.0501	CbGbCtD
Telmisartan—ABCB1—Vincristine—sarcoma	0.0248	0.0345	CbGbCtD
Telmisartan—ABCB1—Etoposide—sarcoma	0.0227	0.0316	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—sarcoma	0.0155	0.0216	CbGbCtD
Telmisartan—PPARG—dermis—sarcoma	0.00909	0.107	CbGeAlD
Telmisartan—PPARG—periosteum—sarcoma	0.00753	0.0883	CbGeAlD
Telmisartan—PPARG—leg—sarcoma	0.006	0.0704	CbGeAlD
Telmisartan—PPARG—forelimb—sarcoma	0.00596	0.0699	CbGeAlD
Telmisartan—PPARG—hindlimb—sarcoma	0.00536	0.0629	CbGeAlD
Telmisartan—PPARG—appendage—sarcoma	0.0046	0.054	CbGeAlD
Telmisartan—PPARG—Teniposide—Etoposide—sarcoma	0.00398	1	CbGdCrCtD
Telmisartan—AGTR1—endothelium—sarcoma	0.00337	0.0396	CbGeAlD
Telmisartan—PPARG—endothelium—sarcoma	0.00278	0.0326	CbGeAlD
Telmisartan—PPARG—mammary gland—sarcoma	0.00224	0.0262	CbGeAlD
Telmisartan—AGTR1—myometrium—sarcoma	0.00193	0.0226	CbGeAlD
Telmisartan—AGTR1—hematopoietic system—sarcoma	0.00166	0.0194	CbGeAlD
Telmisartan—AGTR1—connective tissue—sarcoma	0.0016	0.0187	CbGeAlD
Telmisartan—PPARG—embryo—sarcoma	0.00153	0.0179	CbGeAlD
Telmisartan—AGTR1—smooth muscle tissue—sarcoma	0.00146	0.0171	CbGeAlD
Telmisartan—SLCO1B3—liver—sarcoma	0.00142	0.0166	CbGeAlD
Telmisartan—PPARG—hematopoietic system—sarcoma	0.00136	0.016	CbGeAlD
Telmisartan—PPARG—connective tissue—sarcoma	0.00131	0.0154	CbGeAlD
Telmisartan—AGTR1—cardiac atrium—sarcoma	0.00126	0.0148	CbGeAlD
Telmisartan—PPARG—smooth muscle tissue—sarcoma	0.0012	0.0141	CbGeAlD
Telmisartan—PPARG—skin of body—sarcoma	0.00118	0.0139	CbGeAlD
Telmisartan—AGTR1—lymphoid tissue—sarcoma	0.00117	0.0137	CbGeAlD
Telmisartan—AGTR1—tendon—sarcoma	0.0011	0.0129	CbGeAlD
Telmisartan—PPARG—uterus—sarcoma	0.00103	0.0121	CbGeAlD
Telmisartan—CYP2C19—hematopoietic system—sarcoma	0.00103	0.0121	CbGeAlD
Telmisartan—ABCG2—myometrium—sarcoma	0.00102	0.0119	CbGeAlD
Telmisartan—PPARG—lymphoid tissue—sarcoma	0.000959	0.0113	CbGeAlD
Telmisartan—ABCG2—seminal vesicle—sarcoma	0.000919	0.0108	CbGeAlD
Telmisartan—AGTR1—testis—sarcoma	0.000908	0.0107	CbGeAlD
Telmisartan—PPARG—tendon—sarcoma	0.000902	0.0106	CbGeAlD
Telmisartan—PPARG—bone marrow—sarcoma	0.000874	0.0103	CbGeAlD
Telmisartan—AGTR1—liver—sarcoma	0.000859	0.0101	CbGeAlD
Telmisartan—ABCC2—tendon—sarcoma	0.000793	0.0093	CbGeAlD
Telmisartan—PPARG—testis—sarcoma	0.000747	0.00876	CbGeAlD
Telmisartan—PPARG—liver—sarcoma	0.000706	0.00829	CbGeAlD
Telmisartan—ABCG2—uterus—sarcoma	0.00066	0.00774	CbGeAlD
Telmisartan—AGTR1—lymph node—sarcoma	0.000658	0.00772	CbGeAlD
Telmisartan—ABCC2—testis—sarcoma	0.000656	0.0077	CbGeAlD
Telmisartan—ABCC2—liver—sarcoma	0.000621	0.00728	CbGeAlD
Telmisartan—ABCG2—bone marrow—sarcoma	0.00056	0.00657	CbGeAlD
Telmisartan—PPARG—lymph node—sarcoma	0.000541	0.00635	CbGeAlD
Telmisartan—CYP2C19—liver—sarcoma	0.000533	0.00626	CbGeAlD
Telmisartan—ABCB1—myometrium—sarcoma	0.000502	0.00589	CbGeAlD
Telmisartan—ABCB1—embryo—sarcoma	0.000483	0.00566	CbGeAlD
Telmisartan—ABCG2—testis—sarcoma	0.000479	0.00562	CbGeAlD
Telmisartan—ABCC2—lymph node—sarcoma	0.000476	0.00558	CbGeAlD
Telmisartan—ABCB1—seminal vesicle—sarcoma	0.000453	0.00532	CbGeAlD
Telmisartan—ABCG2—liver—sarcoma	0.000453	0.00531	CbGeAlD
Telmisartan—ABCB1—hematopoietic system—sarcoma	0.000431	0.00505	CbGeAlD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TEK—sarcoma	0.000396	0.0532	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—sarcoma	0.000363	0.0487	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—PAX3—sarcoma	0.00035	0.047	CbGpPWpGaD
Telmisartan—ABCG2—lymph node—sarcoma	0.000347	0.00407	CbGeAlD
Telmisartan—ABCB1—uterus—sarcoma	0.000325	0.00382	CbGeAlD
Telmisartan—ABCB1—lymphoid tissue—sarcoma	0.000303	0.00356	CbGeAlD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—TEK—sarcoma	0.000286	0.0384	CbGpPWpGaD
Telmisartan—ABCB1—bone marrow—sarcoma	0.000276	0.00324	CbGeAlD
Telmisartan—PPARG—Regulation of retinoblastoma protein—SMARCB1—sarcoma	0.000254	0.0341	CbGpPWpGaD
Telmisartan—ABCB1—testis—sarcoma	0.000236	0.00277	CbGeAlD
Telmisartan—Diarrhoea—Thiotepa—sarcoma	0.000233	0.00127	CcSEcCtD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—FOXO1—sarcoma	0.000233	0.0313	CbGpPWpGaD
Telmisartan—Body temperature increased—Mitoxantrone—sarcoma	0.000233	0.00126	CcSEcCtD
Telmisartan—Abdominal pain—Mitoxantrone—sarcoma	0.000233	0.00126	CcSEcCtD
Telmisartan—Bronchitis—Epirubicin—sarcoma	0.000232	0.00126	CcSEcCtD
Telmisartan—Diarrhoea—Dactinomycin—sarcoma	0.000232	0.00126	CcSEcCtD
Telmisartan—Hypotension—Etoposide—sarcoma	0.000229	0.00124	CcSEcCtD
Telmisartan—Gastritis—Doxorubicin—sarcoma	0.000229	0.00124	CcSEcCtD
Telmisartan—Muscular weakness—Doxorubicin—sarcoma	0.000228	0.00124	CcSEcCtD
Telmisartan—Dysuria—Epirubicin—sarcoma	0.000226	0.00123	CcSEcCtD
Telmisartan—Dizziness—Thiotepa—sarcoma	0.000226	0.00122	CcSEcCtD
Telmisartan—Abdominal distension—Doxorubicin—sarcoma	0.000225	0.00122	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Epirubicin—sarcoma	0.000225	0.00122	CcSEcCtD
Telmisartan—Asthma—Doxorubicin—sarcoma	0.000224	0.00121	CcSEcCtD
Telmisartan—ABCB1—liver—sarcoma	0.000223	0.00262	CbGeAlD
Telmisartan—Pollakiuria—Epirubicin—sarcoma	0.000223	0.00121	CcSEcCtD
Telmisartan—Hypersensitivity—Vincristine—sarcoma	0.000223	0.00121	CcSEcCtD
Telmisartan—Eosinophilia—Doxorubicin—sarcoma	0.000221	0.0012	CcSEcCtD
Telmisartan—Paraesthesia—Etoposide—sarcoma	0.00022	0.00119	CcSEcCtD
Telmisartan—Dyspnoea—Etoposide—sarcoma	0.000218	0.00119	CcSEcCtD
Telmisartan—Somnolence—Etoposide—sarcoma	0.000218	0.00118	CcSEcCtD
Telmisartan—Angina pectoris—Doxorubicin—sarcoma	0.000218	0.00118	CcSEcCtD
Telmisartan—Hypersensitivity—Mitoxantrone—sarcoma	0.000217	0.00118	CcSEcCtD
Telmisartan—Asthenia—Vincristine—sarcoma	0.000217	0.00118	CcSEcCtD
Telmisartan—Vomiting—Thiotepa—sarcoma	0.000217	0.00118	CcSEcCtD
Telmisartan—Pneumonia—Epirubicin—sarcoma	0.000217	0.00118	CcSEcCtD
Telmisartan—Infestation—Epirubicin—sarcoma	0.000215	0.00117	CcSEcCtD
Telmisartan—Infestation NOS—Epirubicin—sarcoma	0.000215	0.00117	CcSEcCtD
Telmisartan—Vomiting—Dactinomycin—sarcoma	0.000215	0.00117	CcSEcCtD
Telmisartan—Rash—Thiotepa—sarcoma	0.000215	0.00117	CcSEcCtD
Telmisartan—Bronchitis—Doxorubicin—sarcoma	0.000215	0.00117	CcSEcCtD
Telmisartan—Dermatitis—Thiotepa—sarcoma	0.000215	0.00117	CcSEcCtD
Telmisartan—Headache—Thiotepa—sarcoma	0.000214	0.00116	CcSEcCtD
Telmisartan—Rash—Dactinomycin—sarcoma	0.000214	0.00116	CcSEcCtD
Telmisartan—Decreased appetite—Etoposide—sarcoma	0.000213	0.00116	CcSEcCtD
Telmisartan—Renal failure—Epirubicin—sarcoma	0.000212	0.00115	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Etoposide—sarcoma	0.000212	0.00115	CcSEcCtD
Telmisartan—Asthenia—Mitoxantrone—sarcoma	0.000211	0.00115	CcSEcCtD
Telmisartan—Fatigue—Etoposide—sarcoma	0.000211	0.00115	CcSEcCtD
Telmisartan—Neuropathy peripheral—Epirubicin—sarcoma	0.000211	0.00115	CcSEcCtD
Telmisartan—Constipation—Etoposide—sarcoma	0.00021	0.00114	CcSEcCtD
Telmisartan—Pain—Etoposide—sarcoma	0.00021	0.00114	CcSEcCtD
Telmisartan—Urinary tract infection—Epirubicin—sarcoma	0.000209	0.00114	CcSEcCtD
Telmisartan—Conjunctivitis—Epirubicin—sarcoma	0.000209	0.00114	CcSEcCtD
Telmisartan—Dysuria—Doxorubicin—sarcoma	0.000209	0.00113	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000208	0.00113	CcSEcCtD
Telmisartan—Diarrhoea—Vincristine—sarcoma	0.000207	0.00112	CcSEcCtD
Telmisartan—Pollakiuria—Doxorubicin—sarcoma	0.000206	0.00112	CcSEcCtD
Telmisartan—Haematuria—Epirubicin—sarcoma	0.000205	0.00112	CcSEcCtD
Telmisartan—Hepatobiliary disease—Epirubicin—sarcoma	0.000204	0.00111	CcSEcCtD
Telmisartan—Epistaxis—Epirubicin—sarcoma	0.000203	0.0011	CcSEcCtD
Telmisartan—Nausea—Thiotepa—sarcoma	0.000203	0.0011	CcSEcCtD
Telmisartan—Sinusitis—Epirubicin—sarcoma	0.000202	0.0011	CcSEcCtD
Telmisartan—Feeling abnormal—Etoposide—sarcoma	0.000202	0.0011	CcSEcCtD
Telmisartan—Diarrhoea—Mitoxantrone—sarcoma	0.000202	0.00109	CcSEcCtD
Telmisartan—Nausea—Dactinomycin—sarcoma	0.000201	0.00109	CcSEcCtD
Telmisartan—Pneumonia—Doxorubicin—sarcoma	0.0002	0.00109	CcSEcCtD
Telmisartan—Gastrointestinal pain—Etoposide—sarcoma	0.0002	0.00109	CcSEcCtD
Telmisartan—Dizziness—Vincristine—sarcoma	0.0002	0.00109	CcSEcCtD
Telmisartan—Infestation—Doxorubicin—sarcoma	0.000199	0.00108	CcSEcCtD
Telmisartan—Infestation NOS—Doxorubicin—sarcoma	0.000199	0.00108	CcSEcCtD
Telmisartan—Bradycardia—Epirubicin—sarcoma	0.000197	0.00107	CcSEcCtD
Telmisartan—Renal failure—Doxorubicin—sarcoma	0.000196	0.00106	CcSEcCtD
Telmisartan—Neuropathy peripheral—Doxorubicin—sarcoma	0.000195	0.00106	CcSEcCtD
Telmisartan—Urticaria—Etoposide—sarcoma	0.000195	0.00106	CcSEcCtD
Telmisartan—Rhinitis—Epirubicin—sarcoma	0.000194	0.00105	CcSEcCtD
Telmisartan—Abdominal pain—Etoposide—sarcoma	0.000194	0.00105	CcSEcCtD
Telmisartan—Body temperature increased—Etoposide—sarcoma	0.000194	0.00105	CcSEcCtD
Telmisartan—Urinary tract infection—Doxorubicin—sarcoma	0.000194	0.00105	CcSEcCtD
Telmisartan—Conjunctivitis—Doxorubicin—sarcoma	0.000194	0.00105	CcSEcCtD
Telmisartan—PPARG—Regulation of retinoblastoma protein—MYOD1—sarcoma	0.000193	0.0259	CbGpPWpGaD
Telmisartan—Hypoaesthesia—Epirubicin—sarcoma	0.000192	0.00104	CcSEcCtD
Telmisartan—Vomiting—Vincristine—sarcoma	0.000192	0.00104	CcSEcCtD
Telmisartan—Pharyngitis—Epirubicin—sarcoma	0.000192	0.00104	CcSEcCtD
Telmisartan—Urinary tract disorder—Epirubicin—sarcoma	0.000191	0.00104	CcSEcCtD
Telmisartan—Rash—Vincristine—sarcoma	0.000191	0.00104	CcSEcCtD
Telmisartan—Dermatitis—Vincristine—sarcoma	0.000191	0.00103	CcSEcCtD
Telmisartan—Oedema peripheral—Epirubicin—sarcoma	0.00019	0.00103	CcSEcCtD
Telmisartan—Haematuria—Doxorubicin—sarcoma	0.00019	0.00103	CcSEcCtD
Telmisartan—Connective tissue disorder—Epirubicin—sarcoma	0.00019	0.00103	CcSEcCtD
Telmisartan—Urethral disorder—Epirubicin—sarcoma	0.00019	0.00103	CcSEcCtD
Telmisartan—Headache—Vincristine—sarcoma	0.00019	0.00103	CcSEcCtD
Telmisartan—Hepatobiliary disease—Doxorubicin—sarcoma	0.000188	0.00102	CcSEcCtD
Telmisartan—Epistaxis—Doxorubicin—sarcoma	0.000188	0.00102	CcSEcCtD
Telmisartan—Vomiting—Mitoxantrone—sarcoma	0.000187	0.00102	CcSEcCtD
Telmisartan—Sinusitis—Doxorubicin—sarcoma	0.000187	0.00102	CcSEcCtD
Telmisartan—Visual impairment—Epirubicin—sarcoma	0.000186	0.00101	CcSEcCtD
Telmisartan—Rash—Mitoxantrone—sarcoma	0.000186	0.00101	CcSEcCtD
Telmisartan—Dermatitis—Mitoxantrone—sarcoma	0.000186	0.00101	CcSEcCtD
Telmisartan—Headache—Mitoxantrone—sarcoma	0.000185	0.001	CcSEcCtD
Telmisartan—Bradycardia—Doxorubicin—sarcoma	0.000182	0.000989	CcSEcCtD
Telmisartan—Eye disorder—Epirubicin—sarcoma	0.000181	0.000981	CcSEcCtD
Telmisartan—Hypersensitivity—Etoposide—sarcoma	0.000181	0.00098	CcSEcCtD
Telmisartan—Tinnitus—Epirubicin—sarcoma	0.00018	0.000979	CcSEcCtD
Telmisartan—Nausea—Vincristine—sarcoma	0.00018	0.000976	CcSEcCtD
Telmisartan—Cardiac disorder—Epirubicin—sarcoma	0.000179	0.000974	CcSEcCtD
Telmisartan—Flushing—Epirubicin—sarcoma	0.000179	0.000974	CcSEcCtD
Telmisartan—Rhinitis—Doxorubicin—sarcoma	0.000179	0.000974	CcSEcCtD
Telmisartan—PPARG—Regulation of retinoblastoma protein—MITF—sarcoma	0.000179	0.024	CbGpPWpGaD
Telmisartan—Hypoaesthesia—Doxorubicin—sarcoma	0.000178	0.000966	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—sarcoma	0.000178	0.000964	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—sarcoma	0.000177	0.000959	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—sarcoma	0.000176	0.000957	CcSEcCtD
Telmisartan—Asthenia—Etoposide—sarcoma	0.000176	0.000955	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—sarcoma	0.000176	0.000955	CcSEcCtD
Telmisartan—Angiopathy—Epirubicin—sarcoma	0.000175	0.000952	CcSEcCtD
Telmisartan—Urethral disorder—Doxorubicin—sarcoma	0.000175	0.000952	CcSEcCtD
Telmisartan—Nausea—Mitoxantrone—sarcoma	0.000175	0.00095	CcSEcCtD
Telmisartan—Immune system disorder—Epirubicin—sarcoma	0.000175	0.000948	CcSEcCtD
Telmisartan—Mediastinal disorder—Epirubicin—sarcoma	0.000174	0.000946	CcSEcCtD
Telmisartan—Chills—Epirubicin—sarcoma	0.000174	0.000942	CcSEcCtD
Telmisartan—Pruritus—Etoposide—sarcoma	0.000173	0.000941	CcSEcCtD
Telmisartan—Arrhythmia—Epirubicin—sarcoma	0.000173	0.000938	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—sarcoma	0.000172	0.000936	CcSEcCtD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—FLT1—sarcoma	0.000172	0.0231	CbGpPWpGaD
Telmisartan—ABCB1—lymph node—sarcoma	0.000171	0.00201	CbGeAlD
Telmisartan—Mental disorder—Epirubicin—sarcoma	0.000169	0.00092	CcSEcCtD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—CREB1—sarcoma	0.000169	0.0227	CbGpPWpGaD
Telmisartan—Erythema—Epirubicin—sarcoma	0.000168	0.000914	CcSEcCtD
Telmisartan—Malnutrition—Epirubicin—sarcoma	0.000168	0.000914	CcSEcCtD
Telmisartan—Diarrhoea—Etoposide—sarcoma	0.000168	0.00091	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—sarcoma	0.000167	0.000908	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—sarcoma	0.000167	0.000906	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—sarcoma	0.000166	0.000901	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—sarcoma	0.000166	0.000901	CcSEcCtD
Telmisartan—Flatulence—Epirubicin—sarcoma	0.000166	0.000901	CcSEcCtD
Telmisartan—Tension—Epirubicin—sarcoma	0.000165	0.000897	CcSEcCtD
Telmisartan—Dysgeusia—Epirubicin—sarcoma	0.000165	0.000895	CcSEcCtD
Telmisartan—Nervousness—Epirubicin—sarcoma	0.000163	0.000888	CcSEcCtD
Telmisartan—Back pain—Epirubicin—sarcoma	0.000163	0.000884	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—sarcoma	0.000162	0.000881	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FOXO1—sarcoma	0.000162	0.0218	CbGpPWpGaD
Telmisartan—Dizziness—Etoposide—sarcoma	0.000162	0.00088	CcSEcCtD
Telmisartan—Muscle spasms—Epirubicin—sarcoma	0.000162	0.000879	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—sarcoma	0.000162	0.000877	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—sarcoma	0.000161	0.000875	CcSEcCtD
Telmisartan—Chills—Doxorubicin—sarcoma	0.000161	0.000872	CcSEcCtD
Telmisartan—AGTR1—Peptide GPCRs—CXCR4—sarcoma	0.000161	0.0215	CbGpPWpGaD
Telmisartan—Arrhythmia—Doxorubicin—sarcoma	0.00016	0.000868	CcSEcCtD
Telmisartan—ABCG2—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000159	0.0214	CbGpPWpGaD
Telmisartan—Mental disorder—Doxorubicin—sarcoma	0.000157	0.000851	CcSEcCtD
Telmisartan—Ill-defined disorder—Epirubicin—sarcoma	0.000156	0.000848	CcSEcCtD
Telmisartan—Vomiting—Etoposide—sarcoma	0.000156	0.000846	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—sarcoma	0.000156	0.000846	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—sarcoma	0.000156	0.000846	CcSEcCtD
Telmisartan—Anaemia—Epirubicin—sarcoma	0.000156	0.000845	CcSEcCtD
Telmisartan—Rash—Etoposide—sarcoma	0.000155	0.000839	CcSEcCtD
Telmisartan—Dermatitis—Etoposide—sarcoma	0.000154	0.000838	CcSEcCtD
Telmisartan—Headache—Etoposide—sarcoma	0.000154	0.000834	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—sarcoma	0.000153	0.000833	CcSEcCtD
Telmisartan—Tension—Doxorubicin—sarcoma	0.000153	0.00083	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—sarcoma	0.000153	0.000828	CcSEcCtD
Telmisartan—Malaise—Epirubicin—sarcoma	0.000152	0.000824	CcSEcCtD
Telmisartan—Nervousness—Doxorubicin—sarcoma	0.000151	0.000821	CcSEcCtD
Telmisartan—Vertigo—Epirubicin—sarcoma	0.000151	0.000821	CcSEcCtD
Telmisartan—Syncope—Epirubicin—sarcoma	0.000151	0.00082	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—sarcoma	0.000151	0.000818	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—sarcoma	0.00015	0.000813	CcSEcCtD
Telmisartan—Palpitations—Epirubicin—sarcoma	0.000149	0.000808	CcSEcCtD
Telmisartan—Loss of consciousness—Epirubicin—sarcoma	0.000148	0.000803	CcSEcCtD
Telmisartan—Cough—Epirubicin—sarcoma	0.000147	0.000797	CcSEcCtD
Telmisartan—Nausea—Etoposide—sarcoma	0.000146	0.00079	CcSEcCtD
Telmisartan—Hypertension—Epirubicin—sarcoma	0.000145	0.000789	CcSEcCtD
Telmisartan—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000145	0.0194	CbGpPWpGaD
Telmisartan—Ill-defined disorder—Doxorubicin—sarcoma	0.000145	0.000785	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—sarcoma	0.000144	0.000782	CcSEcCtD
Telmisartan—Arthralgia—Epirubicin—sarcoma	0.000143	0.000778	CcSEcCtD
Telmisartan—Chest pain—Epirubicin—sarcoma	0.000143	0.000778	CcSEcCtD
Telmisartan—Myalgia—Epirubicin—sarcoma	0.000143	0.000778	CcSEcCtD
Telmisartan—Anxiety—Epirubicin—sarcoma	0.000143	0.000775	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000142	0.000773	CcSEcCtD
Telmisartan—Discomfort—Epirubicin—sarcoma	0.000142	0.000769	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—sarcoma	0.00014	0.000763	CcSEcCtD
Telmisartan—Dry mouth—Epirubicin—sarcoma	0.00014	0.000761	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—sarcoma	0.00014	0.00076	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—sarcoma	0.00014	0.000758	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—sarcoma	0.000138	0.000747	CcSEcCtD
Telmisartan—Anaphylactic shock—Epirubicin—sarcoma	0.000137	0.000746	CcSEcCtD
Telmisartan—Oedema—Epirubicin—sarcoma	0.000137	0.000746	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—sarcoma	0.000137	0.000743	CcSEcCtD
Telmisartan—Infection—Epirubicin—sarcoma	0.000136	0.000741	CcSEcCtD
Telmisartan—Cough—Doxorubicin—sarcoma	0.000136	0.000738	CcSEcCtD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000135	0.0181	CbGpPWpGaD
Telmisartan—Shock—Epirubicin—sarcoma	0.000135	0.000734	CcSEcCtD
Telmisartan—Nervous system disorder—Epirubicin—sarcoma	0.000135	0.000731	CcSEcCtD
Telmisartan—Thrombocytopenia—Epirubicin—sarcoma	0.000135	0.00073	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—sarcoma	0.000134	0.00073	CcSEcCtD
Telmisartan—Tachycardia—Epirubicin—sarcoma	0.000134	0.000728	CcSEcCtD
Telmisartan—Skin disorder—Epirubicin—sarcoma	0.000133	0.000724	CcSEcCtD
Telmisartan—Hyperhidrosis—Epirubicin—sarcoma	0.000133	0.000721	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—sarcoma	0.000133	0.00072	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—sarcoma	0.000133	0.00072	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—sarcoma	0.000133	0.00072	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—sarcoma	0.000132	0.000717	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000132	0.000715	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—sarcoma	0.000131	0.000711	CcSEcCtD
Telmisartan—Anorexia—Epirubicin—sarcoma	0.000131	0.000711	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—sarcoma	0.00013	0.000704	CcSEcCtD
Telmisartan—Hypotension—Epirubicin—sarcoma	0.000128	0.000697	CcSEcCtD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000128	0.0172	CbGpPWpGaD
Telmisartan—Anaphylactic shock—Doxorubicin—sarcoma	0.000127	0.00069	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—sarcoma	0.000127	0.00069	CcSEcCtD
Telmisartan—Infection—Doxorubicin—sarcoma	0.000126	0.000686	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000125	0.00068	CcSEcCtD
Telmisartan—Shock—Doxorubicin—sarcoma	0.000125	0.000679	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—sarcoma	0.000125	0.000677	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—sarcoma	0.000124	0.000676	CcSEcCtD
Telmisartan—Insomnia—Epirubicin—sarcoma	0.000124	0.000675	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—sarcoma	0.000124	0.000674	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—sarcoma	0.000123	0.00067	CcSEcCtD
Telmisartan—Paraesthesia—Epirubicin—sarcoma	0.000123	0.00067	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—sarcoma	0.000123	0.000667	CcSEcCtD
Telmisartan—Dyspnoea—Epirubicin—sarcoma	0.000122	0.000665	CcSEcCtD
Telmisartan—Somnolence—Epirubicin—sarcoma	0.000122	0.000663	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—sarcoma	0.000121	0.000658	CcSEcCtD
Telmisartan—Dyspepsia—Epirubicin—sarcoma	0.000121	0.000657	CcSEcCtD
Telmisartan—Decreased appetite—Epirubicin—sarcoma	0.000119	0.000648	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—sarcoma	0.000119	0.000645	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Epirubicin—sarcoma	0.000119	0.000644	CcSEcCtD
Telmisartan—Fatigue—Epirubicin—sarcoma	0.000118	0.000643	CcSEcCtD
Telmisartan—Pain—Epirubicin—sarcoma	0.000117	0.000638	CcSEcCtD
Telmisartan—Constipation—Epirubicin—sarcoma	0.000117	0.000638	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000116	0.000629	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—sarcoma	0.000115	0.000624	CcSEcCtD
Telmisartan—Paraesthesia—Doxorubicin—sarcoma	0.000114	0.00062	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—sarcoma	0.000113	0.000615	CcSEcCtD
Telmisartan—Feeling abnormal—Epirubicin—sarcoma	0.000113	0.000615	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—sarcoma	0.000113	0.000614	CcSEcCtD
Telmisartan—Gastrointestinal pain—Epirubicin—sarcoma	0.000112	0.00061	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—sarcoma	0.000112	0.000607	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—PDGFRA—sarcoma	0.000111	0.0148	CbGpPWpGaD
Telmisartan—Decreased appetite—Doxorubicin—sarcoma	0.00011	0.0006	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00011	0.000596	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—sarcoma	0.00011	0.000595	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—sarcoma	0.00011	0.0147	CbGpPWpGaD
Telmisartan—Urticaria—Epirubicin—sarcoma	0.000109	0.000593	CcSEcCtD
Telmisartan—Pain—Doxorubicin—sarcoma	0.000109	0.00059	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—sarcoma	0.000109	0.00059	CcSEcCtD
Telmisartan—Abdominal pain—Epirubicin—sarcoma	0.000109	0.00059	CcSEcCtD
Telmisartan—Body temperature increased—Epirubicin—sarcoma	0.000109	0.00059	CcSEcCtD
Telmisartan—Feeling abnormal—Doxorubicin—sarcoma	0.000105	0.000569	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—sarcoma	0.000104	0.000564	CcSEcCtD
Telmisartan—Hypersensitivity—Epirubicin—sarcoma	0.000101	0.00055	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—sarcoma	0.000101	0.000548	CcSEcCtD
Telmisartan—AGTR1—Arf6 signaling events—SRC—sarcoma	0.000101	0.0135	CbGpPWpGaD
Telmisartan—Abdominal pain—Doxorubicin—sarcoma	0.0001	0.000546	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—sarcoma	0.0001	0.000546	CcSEcCtD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—KDR—sarcoma	9.92e-05	0.0133	CbGpPWpGaD
Telmisartan—Asthenia—Epirubicin—sarcoma	9.86e-05	0.000535	CcSEcCtD
Telmisartan—Pruritus—Epirubicin—sarcoma	9.72e-05	0.000528	CcSEcCtD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—CXCR4—sarcoma	9.55e-05	0.0128	CbGpPWpGaD
Telmisartan—Diarrhoea—Epirubicin—sarcoma	9.4e-05	0.00051	CcSEcCtD
Telmisartan—Hypersensitivity—Doxorubicin—sarcoma	9.37e-05	0.000508	CcSEcCtD
Telmisartan—Asthenia—Doxorubicin—sarcoma	9.12e-05	0.000495	CcSEcCtD
Telmisartan—Dizziness—Epirubicin—sarcoma	9.08e-05	0.000493	CcSEcCtD
Telmisartan—Pruritus—Doxorubicin—sarcoma	8.99e-05	0.000488	CcSEcCtD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	8.93e-05	0.012	CbGpPWpGaD
Telmisartan—AGTR1—Arf6 signaling events—EGFR—sarcoma	8.85e-05	0.0119	CbGpPWpGaD
Telmisartan—AGTR1—Arf6 trafficking events—CTNNB1—sarcoma	8.82e-05	0.0118	CbGpPWpGaD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	8.79e-05	0.0118	CbGpPWpGaD
Telmisartan—Vomiting—Epirubicin—sarcoma	8.73e-05	0.000474	CcSEcCtD
Telmisartan—Diarrhoea—Doxorubicin—sarcoma	8.7e-05	0.000472	CcSEcCtD
Telmisartan—Rash—Epirubicin—sarcoma	8.66e-05	0.00047	CcSEcCtD
Telmisartan—Dermatitis—Epirubicin—sarcoma	8.65e-05	0.00047	CcSEcCtD
Telmisartan—Headache—Epirubicin—sarcoma	8.61e-05	0.000467	CcSEcCtD
Telmisartan—Dizziness—Doxorubicin—sarcoma	8.41e-05	0.000456	CcSEcCtD
Telmisartan—Nausea—Epirubicin—sarcoma	8.16e-05	0.000443	CcSEcCtD
Telmisartan—Vomiting—Doxorubicin—sarcoma	8.08e-05	0.000439	CcSEcCtD
Telmisartan—Rash—Doxorubicin—sarcoma	8.01e-05	0.000435	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—sarcoma	8.01e-05	0.000435	CcSEcCtD
Telmisartan—Headache—Doxorubicin—sarcoma	7.96e-05	0.000432	CcSEcCtD
Telmisartan—Nausea—Doxorubicin—sarcoma	7.55e-05	0.00041	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CXCR4—sarcoma	7.55e-05	0.0101	CbGpPWpGaD
Telmisartan—CYP2C19—Melatonin metabolism and effects—FOXO1—sarcoma	7.54e-05	0.0101	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	7.31e-05	0.00981	CbGpPWpGaD
Telmisartan—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	6.97e-05	0.00936	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	6.94e-05	0.00931	CbGpPWpGaD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	6.82e-05	0.00915	CbGpPWpGaD
Telmisartan—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	6.8e-05	0.00913	CbGpPWpGaD
Telmisartan—PPARG—SREBP signalling—CREB1—sarcoma	6.77e-05	0.00909	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—sarcoma	6.48e-05	0.00869	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—sarcoma	6.3e-05	0.00845	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MYOG—sarcoma	6.23e-05	0.00836	CbGpPWpGaD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—CCND1—sarcoma	6.12e-05	0.00821	CbGpPWpGaD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—CTNNB1—sarcoma	6.06e-05	0.00813	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL2—sarcoma	6.03e-05	0.0081	CbGpPWpGaD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	5.91e-05	0.00793	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—MDM2—sarcoma	5.8e-05	0.00779	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—FOXO1—sarcoma	5.62e-05	0.00755	CbGpPWpGaD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—sarcoma	5.46e-05	0.00733	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	5.16e-05	0.00693	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—VEGFA—sarcoma	5.13e-05	0.00688	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—CREB1—sarcoma	5.12e-05	0.00686	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	5.06e-05	0.0068	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CCND1—sarcoma	5.06e-05	0.00679	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—JUN—sarcoma	5.05e-05	0.00677	CbGpPWpGaD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—MYC—sarcoma	4.91e-05	0.00659	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	4.83e-05	0.00648	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	4.76e-05	0.00638	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EZR—sarcoma	4.72e-05	0.00634	CbGpPWpGaD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TP53—sarcoma	4.23e-05	0.00567	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—CREB1—sarcoma	4.08e-05	0.00547	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CXCR4—sarcoma	3.86e-05	0.00518	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MYOD1—sarcoma	3.85e-05	0.00517	CbGpPWpGaD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	3.75e-05	0.00504	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	3.69e-05	0.00495	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	3.68e-05	0.00494	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—sarcoma	3.66e-05	0.00492	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—PDGFRA—sarcoma	3.24e-05	0.00435	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	3.21e-05	0.00431	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—FUS—sarcoma	3.19e-05	0.00428	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	3.02e-05	0.00405	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—CTNNB1—sarcoma	2.91e-05	0.00391	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—CREB1—sarcoma	2.88e-05	0.00386	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—PTPRC—sarcoma	2.78e-05	0.00374	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	2.77e-05	0.00371	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—PLCG1—sarcoma	2.72e-05	0.00366	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	2.27e-05	0.00305	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCR4—sarcoma	2.18e-05	0.00292	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	2.07e-05	0.00278	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—JUN—sarcoma	2.07e-05	0.00278	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	2.03e-05	0.00272	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	1.99e-05	0.00267	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCR4—sarcoma	1.98e-05	0.00266	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	1.96e-05	0.00263	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—FOXO1—sarcoma	1.93e-05	0.00259	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TLE1—sarcoma	1.84e-05	0.00246	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL2—sarcoma	1.77e-05	0.00238	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	1.74e-05	0.00233	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	1.66e-05	0.00223	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	1.6e-05	0.00215	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KDR—sarcoma	1.6e-05	0.00215	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFC—sarcoma	1.55e-05	0.00208	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—VEGFA—sarcoma	1.5e-05	0.00202	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ENO2—sarcoma	1.5e-05	0.00201	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—HBA1—sarcoma	1.49e-05	0.002	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CREB1—sarcoma	1.4e-05	0.00188	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—sarcoma	1.37e-05	0.00183	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP2—sarcoma	1.31e-05	0.00175	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ENO2—sarcoma	1.28e-05	0.00171	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PLCG1—sarcoma	1.27e-05	0.0017	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—HBA1—sarcoma	1.27e-05	0.0017	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FLT1—sarcoma	1.24e-05	0.00166	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PLCG1—sarcoma	1.22e-05	0.00163	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	1.18e-05	0.00159	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCR4—sarcoma	1.17e-05	0.00157	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ATF1—sarcoma	1.16e-05	0.00155	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PLCG1—sarcoma	1.08e-05	0.00145	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CREB1—sarcoma	1.06e-05	0.00142	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CTNNB1—sarcoma	1e-05	0.00134	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	9.78e-06	0.00131	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ENO2—sarcoma	9.31e-06	0.00125	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HBA1—sarcoma	9.25e-06	0.00124	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IGF1R—sarcoma	9.07e-06	0.00122	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—SRC—sarcoma	9.04e-06	0.00121	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—sarcoma	8.81e-06	0.00118	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NRAS—sarcoma	8.7e-06	0.00117	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FOXO1—sarcoma	8.63e-06	0.00116	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2—sarcoma	8.63e-06	0.00116	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PDGFRB—sarcoma	8.62e-06	0.00116	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—sarcoma	8.61e-06	0.00116	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	8.52e-06	0.00114	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	8.5e-06	0.00114	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PDGFRA—sarcoma	8.48e-06	0.00114	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	8.44e-06	0.00113	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EGFR—sarcoma	7.93e-06	0.00106	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PLCG1—sarcoma	7.9e-06	0.00106	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2—sarcoma	7.84e-06	0.00105	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	7.62e-06	0.00102	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KRAS—sarcoma	7.49e-06	0.001	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	7.43e-06	0.000997	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KDR—sarcoma	7.14e-06	0.000958	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	6.83e-06	0.000917	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	6.68e-06	0.000897	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KIT—sarcoma	6.58e-06	0.000883	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—NRAS—sarcoma	6.58e-06	0.000883	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HRAS—sarcoma	6.36e-06	0.000854	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	6.31e-06	0.000847	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CREB1—sarcoma	6.26e-06	0.00084	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—sarcoma	5.99e-06	0.000804	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—sarcoma	5.66e-06	0.00076	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	5.61e-06	0.000753	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MDM2—sarcoma	5.18e-06	0.000695	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ENO2—sarcoma	5.16e-06	0.000692	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HBA1—sarcoma	5.12e-06	0.000688	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ENO2—sarcoma	5.03e-06	0.000676	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HBA1—sarcoma	5e-06	0.000671	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HRAS—sarcoma	4.81e-06	0.000646	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—sarcoma	4.63e-06	0.000621	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—sarcoma	4.51e-06	0.000606	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JUN—sarcoma	4.5e-06	0.000604	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CTNNB1—sarcoma	4.47e-06	0.0006	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PLCG1—sarcoma	4.38e-06	0.000587	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PLCG1—sarcoma	4.27e-06	0.000573	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—sarcoma	4.15e-06	0.000556	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SRC—sarcoma	4.04e-06	0.000542	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—sarcoma	3.93e-06	0.000528	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NRAS—sarcoma	3.89e-06	0.000522	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—sarcoma	3.62e-06	0.000486	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—sarcoma	3.54e-06	0.000475	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—sarcoma	3.34e-06	0.000449	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—sarcoma	2.97e-06	0.000399	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HRAS—sarcoma	2.84e-06	0.000382	CbGpPWpGaD
